A Win For Veru Inc.
Mon, Dec 14, 2020 at 05:33 PM
Veru Inc. (VERU:NASDAQ) rocketted at $9.7, representing a gain of 52.6%. On Fri 11 Dec 20, VERU:NASDAQ touched a New 2-Week High of $6.36. The stock appeared on our News Catalysts scanner on Mon 14 Dec 20 at 10:03 AM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Thu 10 Dec 20 at $7.86 with a volume of 52M+.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- Arvinas, Inc. (ARVN:NASDAQ), 95.06%
- Veru Inc. (VERU:NASDAQ), 52.56%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 36.62%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 35.07%
- GasLog Partners LP (GLOP:NYSE), 31.18%
- Big Rock Partners Acquisition Corp. (BRPA:NASDAQ), 29.36%
- Alexion Pharmaceuticals, Inc. (ALXN:NASDAQ), 29.2%
- CooTek (Cayman) Inc. (CTK:NYSE), 28.4%
- Teligent, Inc. (TLGT:NASDAQ), 28.21%
- BioLineRx Ltd. (BLRX:NASDAQ), 26.97%